Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | Bridging the gap between basic & clinical research to achieve personalized therapy in myeloma

Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, talks on the importance of integrating advances in basic research into clinical trials for multiple myeloma and combining novel technologies together in order to provide personalized therapies to patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.